T283: Invasive Ductal Carcinoma Not Otherwise Specified

Netherlands Cancer Institute


Related Models
PDX model Engraftment
Host Strain Name Site Type Material Material Status Passage
NOD SCID GAMMA Not Specified Not Specified Not Specified Not Specified 1, 10, 3, 4, 7
NOD SCID GAMMA mammary fat pad orthotopic tissue fragment Not Specified 0
Model Quality Control
Technique Description Passage
histology concordance between xenograft and patient tumour 10
Publications
Title CircIQCH Sponges MiR-145 To Promote Breast Cancer Progression By Upregulating DNMT3A Expression.
Authors Li Y, Jiang B, He Z ... He X.
Publication year 2020
Journal circIQCH sponges miR-145 to promote breast cancer progression by upregulating DNMT3A expression.
Patient
Sex Female
Race / Ethnicity Not specified / Not Specified
Derived Model T283
Patient Tumor Collection For PDX Model
Collection (Current Model)
Age 68
Diagnosis Invasive Ductal Carcinoma Not Otherwise Specified
Type Primary
PDX Mouse T283
Collection Site breast
Grade 3 ( Classification: )
Stage ( Classification: )
Sample ID Sample Type Engrafted Tumor Passage Data Type Data Available Platform Used Raw Data
T283-primary Patient Tumor Passage NA expression View data Illumina HiSeq2000 (50bp PE) Not Available
T283-primary Patient Tumor Passage NA copy number alteration View data Agilent aCGH Not Available
T283-primary Patient Tumor Passage NA mutation View data Illumina HiSeq (50bp PE) Not Available
T283-xenograft1 Engrafted Tumor Passage 3 copy number alteration View data Agilent aCGH Not Available
T283-xenograft3 Engrafted Tumor Passage 4 mutation View data Illumina HiSeq (50bp PE) Not Available
T283-xenograft5 Engrafted Tumor Passage 10 cytogenetics Data is not available in the Finder immunohistochemistry Not Available
T283-xenograft2 Engrafted Tumor Passage 1 copy number alteration View data Agilent aCGH Not Available
T283-xenograft4 Engrafted Tumor Passage 7 expression View data Illumina HiSeq2000 (50bp PE) Not Available

Sample ID:     Histology:     Tumor Type: Engrafted Tumor     Passage:     Platform: